Welcome to CuriOralRx
Advanced Oral Biologics
Platform Redefining Injectable
Therapies
Oral Biologics. Proven Performance.
CuriOralRx is developing a proprietary oral biologics delivery platform engineered to overcome key physiological barriers to gastrointestinal delivery of fragile biologics. Our patented technology is designed to protect peptides, proteins, and antibody‑based therapeutics from enzymatic degradation and harsh GI conditions, enabling therapeutically meaningful systemic exposure following oral administration.
The platform has demonstrated
- Oral bioavailability in preclinical non‑human primate studies
- Broadly applicable across multiple biologic modalities, peptides, proteins, and antibodies
- Well suited for multi‑hormonal regimens and combination biologic therapies.
- Supports the development of next‑generation oral biologic medicines with the potential to transform treatment paradigms traditionally limited to injectable administration.
Partner with us
Scientific Brief
CuriOralRx
A Breakthrough Oral Biologics Platform
CuriOralRx has developed a proprietary, multicomponent oral formulation platform that enables systemic delivery of biologics, unlocking oral alternatives to therapies long dependent on injections.
Why Choose CuriOralRx
At CuriOralRx, we are redefining the future of oral biologic drug delivery by solving some of the most complex challenges in modern biotechnology. Our proprietary platform is designed to unlock the full therapeutic potential of biologics, peptides, and proteins transforming treatments traditionally limited to injections into patient-friendly oral therapies.
Our mission is simple: make advanced biologic therapies safer, more accessible, and easier for patients to use worldwide.
Lead & Development Programs
Partnering Opportunities in Oral Biologics Therapeutics
Unlocking strategic partnerships to advance transformative oral biologic therapies across insulin, GLP 1, and multi-hormone combinations and your therapeutic molecules.
CuriOralRx is actively seeking partners to accelerate the development and commercialization of next-generation oral biologic therapeutics, for example:
Oral Insulin Programs
Oral GLP‑1 Therapies
Oral Insulin + Pramlintide Combination Therapies
Our proprietary delivery platform is designed to overcome bioavailability challenges and enable clinically meaningful oral administration of peptides, proteins, enzymes, and antibodies, creating differentiated opportunities in disease management.
Oral InsulinDesigned to more closely mimic physiologic insulin delivery
Oral Insulin + Pramlintide Combination
Coordinated metabolic control in a single oral therapy
Oral GLP 1
Improved tolerability and patient acceptance
Oral Human Growth HormonePediatric‑friendly alternative to daily injections
Oral Enzyme Replacement Therapies
Potential applications in rare diseases
CuriOralRx
Investment Opportunity
A next-generation oral biologics platform for forward-thinking biotech investors.
CuriOralRx
Partner with CuriOralRx
Let’s Advance Oral Biologics-Together
CuriOralRX collaborates with pharmaceutical companies, biotech innovators, and investors to unlock oral delivery of biologics that traditionally require injections.
Whether you are exploring partnerships, licensing, co-development, or strategic investment, we look forward to connecting
Pharma & Biotech Partners
Oral biologics, reformulation, lifecycle extension
Investors & Strategic Advisors
Platform validation, growth capital, commercialization
Academic & Clinical Collaborators
Translational research and clinical
development
START THE CONVERSATION
Tell us about your interest and we will respond promptly